Global health R&D at work in California
Using a method developed at the University of California-San Francisco, Stanford University researchers have created a compound, still in early stages, that combats drug-resistant malaria parasites without harm to human cells. Despite global efforts, malaria infects nearly 200 million people each year, mostly in Africa and Asia, and kills more than 400,000—primarily children under five. Scientists are racing to find new treatments before current drugs stop working.